• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

LYS-gamma3-MSH Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5764225

MBS5764225 is an inhibitor targeting Lys-gamma3-MSH. Pro-opiomelanocortin (POMC) derived peptide that stimulates lipolysis More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Lys-gamma3-MSH, Inhibitor
Full Product Name
Lys-gamma3-MSH
Product Gene Name
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
3018.27
Solubility
10% acetonitrile/H2O: 1mg/ml
(<1mg/ml refers to the product slightly soluble or insoluble)
Formula
C128H193N45O39S
SMILES
CC(C)([H])[C@]([H])(N=C(O)[C@]([H])(C/C1=C/C=C(/O)C=C1)N=C(O)[C@](N)([H])CCCCN)C(O)=N[C@@]([H])(CC[S]C)C(O)=NCC(O)=N[C@@]([H])(C/C2=C/N=CN2)C(O)=N[C@@]([H])(C/C3=C/C=CC=C3)C(O)=N[C@@]([H])(CCCNC(=N)N)C(O)=N[C@@]([H])(C/C4=C/NC5=CC=CC=C45)C(O)=N[C@@]([H])(CC(=O)O)C(O)=N[C@@]([H])(CCCNC(=N)N)C(O)=N[C@@]([H])(C/C6=C/C=CC=C6)C(O)=NCC(O)=N[C@@]([H])(CCCNC(=N)N)C(O)=N[C@@]([H])(CCCNC(=N)N)C(O)=N[C@@]([H])(CC(=N)O)C(O)=N[C@@]([H])(CO)C(O)=N[C@@]([H])(CO)C(O)=N[C@@]([H])(CO)C(O)=N[C@@]([H])(CO)C(O)=NCC(O)=N[C@@]([H])(CO)C(O)=N[C@@]([H])(CO)C(O)=NCC(O)=N[C@](C)([H])C(O)=NCC(O)=N[C@@]([H])(CCC(=N)O)C(=O)O
CAS Number
156159-18-1

Product References and Citations for Lys-gamma3-MSH, inhibitor

Wu W, Bi C, Bence A K, et al. Antitumor activity of Chk1 inhibitor LY2606368 as a single agent in SW1990 human pancreas orthotopic tumor model. Cancer Research, 2012, 72(8 Supplement): 1776.
Wu W, Bi C, Bence A K, et al. Antitumor activity of Chk1 inhibitor LY2606368 as a single agent in SW1990 human pancreas orthotopic tumor model. Cancer Research, 2012, 72(8 Supplement): 1776.
Lainchbury M, Matthews T P, McHardy T, et al. Discovery of 3-alkoxyamino-5-(pyridin-2-ylamino) pyrazine-2-carbonitriles as selective, orally bioavailable CHK1 inhibitors. Journal of medicinal chemistry, 2012, 55(22): 10229-10240.
Lainchbury M, Matthews T P, McHardy T, et al. Discovery of 3-alkoxyamino-5-(pyridin-2-ylamino) pyrazine-2-carbonitriles as selective, orally bioavailable CHK1 inhibitors. Journal of medicinal chemistry, 2012, 55(22): 10229-10240.
McNeely S C, Burke T F, DurlandBusbice S, et al. Abstract A108: LY2606368, a second generation Chk1 inhibitor, inhibits growth of ovarian carcinoma xenografts either as monotherapy or in combination with standard-of-care agents. Molecular Cancer Therapeutics, 2011, 10(Supplement 1): A108.
McNeely S C, Burke T F, DurlandBusbice S, et al. Abstract A108: LY2606368, a second generation Chk1 inhibitor, inhibits growth of ovarian carcinoma xenografts either as monotherapy or in combination with standard-of-care agents. Molecular Cancer Therapeutics, 2011, 10(Supplement 1): A108.

Other Notes

Small volumes of Lys-gamma3-MSH, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000